Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
31,654
archived clinical trials in
Cardiology

Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cardio Metabolic Institute
mi
from
Somerset, NJ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardio Metabolic Institute
mi
from
Somerset, NJ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Holy Name Medical Center
mi
from
Teaneck, NJ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Holy Name Medical Center
mi
from
Teaneck, NJ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Total Cardiology Care, LLC
mi
from
Wayne, NJ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Total Cardiology Care, LLC
mi
from
Wayne, NJ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Westwood Cardiology Associates
mi
from
Westwood, NJ
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Westwood Cardiology Associates
mi
from
Westwood, NJ
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Albany Medical College
mi
from
Albany, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Albany Medical College
mi
from
Albany, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Albany Stratton VA Medical Center
mi
from
Albany, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Albany Stratton VA Medical Center
mi
from
Albany, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Buffalo Heart Group, LLC
mi
from
Buffalo, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Buffalo Heart Group, LLC
mi
from
Buffalo, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Bassett Healthcare Network
mi
from
Cooperstown, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Bassett Healthcare Network
mi
from
Cooperstown, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
NYHQ
mi
from
Flushing, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
NYHQ
mi
from
Flushing, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Jamaica Hospital Medical Center
mi
from
Jamaica, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Jamaica Hospital Medical Center
mi
from
Jamaica, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Long Island Heart Associates
mi
from
Mineola, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Long Island Heart Associates
mi
from
Mineola, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Winthrop University Hospital
mi
from
Mineola, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Winthrop University Hospital
mi
from
Mineola, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Long Island Jewish Medical Center
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Queens Long Island Medical Group
mi
from
New Hyde Park, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Queens Long Island Medical Group
mi
from
New Hyde Park, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Chinatown Cardiology, PC
mi
from
New York, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Chinatown Cardiology, PC
mi
from
New York, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
DiGiovanna Institute for Medical Education and Research
mi
from
North Massapequa, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
DiGiovanna Institute for Medical Education and Research
mi
from
North Massapequa, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Champlain Valley Physician Hospital
mi
from
Plattsburgh, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Champlain Valley Physician Hospital
mi
from
Plattsburgh, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cardiology Associates of Schenectady, PC
mi
from
Schenectady, NY
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiology Associates of Schenectady, PC
mi
from
Schenectady, NY
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Clinical Study Center of Asheville, LLC
mi
from
Asheville, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Clinical Study Center of Asheville, LLC
mi
from
Asheville, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Metrolina Internal Medicine
mi
from
Charlotte, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Metrolina Internal Medicine
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Gaffney Health Services
mi
from
Charlotte, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Gaffney Health Services
mi
from
Charlotte, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Eastern Carolina Cardiovascular
mi
from
Elizabeth City, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Eastern Carolina Cardiovascular
mi
from
Elizabeth City, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Eastern Cardiology
mi
from
Greenville, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Eastern Cardiology
mi
from
Greenville, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Northside Clinical Research
mi
from
Lenoir, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Northside Clinical Research
mi
from
Lenoir, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Lake Shore Clinical Research, LLC.
mi
from
Mooresville, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Lake Shore Clinical Research, LLC.
mi
from
Mooresville, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cardiology Associates of Carolinas, PA
mi
from
Morganton, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cardiology Associates of Carolinas, PA
mi
from
Morganton, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Eastern Nephrology Associates, PLLC
mi
from
New Bern, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Eastern Nephrology Associates, PLLC
mi
from
New Bern, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Boice-Willis Clinic
mi
from
Rocky Mount, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Sanford Cardiology
mi
from
Sanford, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Sanford Cardiology
mi
from
Sanford, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Natalie A Doyle, MD PA
mi
from
Wilson, NC
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Natalie A Doyle, MD PA
mi
from
Wilson, NC
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Akron General Medical Center
mi
from
Akron, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Akron General Medical Center
mi
from
Akron, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Ohio University Heritage College of Osteopathic Medicine
mi
from
Athens, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Ohio University Heritage College of Osteopathic Medicine
mi
from
Athens, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
The Lindner Research Center
mi
from
Cincinnati, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
The Lindner Research Center
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Cleveland Clinic
mi
from
Cleveland, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Cleveland Clinic
mi
from
Cleveland, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Dayton Heart Center
mi
from
Dayton, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Dayton Heart Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Dayton Veteran Affairs Medical Center
mi
from
Dayton, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Dayton Veteran Affairs Medical Center
mi
from
Dayton, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Colonnade Medical Group
mi
from
Lancaster, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Colonnade Medical Group
mi
from
Lancaster, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Middletown Cardiovascular Associates
mi
from
Middletown, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Middletown Cardiovascular Associates
mi
from
Middletown, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Comprehensive Heart Care, Inc.
mi
from
Toledo, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Comprehensive Heart Care, Inc.
mi
from
Toledo, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Mount Carmel Clinical Cardiovascular Care
mi
from
Westerville, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Mount Carmel Clinical Cardiovascular Care
mi
from
Westerville, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Premier Physicians
mi
from
Westlake, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Premier Physicians
mi
from
Westlake, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Wooster Heart Group
mi
from
Wooster, OH
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Wooster Heart Group
mi
from
Wooster, OH
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
COR Clinical Research
mi
from
Oklahoma City, OK
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
COR Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Today Clinical Research
mi
from
Oklahoma City, OK
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Today Clinical Research
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Oklahoma State University - Center For Health Sciences
mi
from
Tulsa, OK
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Oklahoma State University - Center For Health Sciences
mi
from
Tulsa, OK
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Samaritan Health Services
mi
from
Corvallis, OR
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Samaritan Health Services
mi
from
Corvallis, OR
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Southern Oregon Cardiology, LLC
mi
from
Medford, OR
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Southern Oregon Cardiology, LLC
mi
from
Medford, OR
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Oregon Health and Science University
mi
from
Portland, OR
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Oregon Health and Science University
mi
from
Portland, OR
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
Center for Clinical Res. Abington Health
mi
from
Abington, PA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
Center for Clinical Res. Abington Health
mi
from
Abington, PA
Click here to add this to my saved trials
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated:  4/3/2018
St. Luke's University Hospital
mi
from
Bethlehem, PA
Cardiovascular Inflammation Reduction Trial
A Randomized, Double-blind, Placebo-controlled, Event-driven Trial of Weekly Low-dose Methotrexate (LDM) in the Prevention of Cardiovascular Events Among Stable Coronary Artery Disease Patients With Type 2 Diabetes or Metabolic Syndrome
Status: Enrolling
Updated: 4/3/2018
St. Luke's University Hospital
mi
from
Bethlehem, PA
Click here to add this to my saved trials